By drawing on the concept of mitochondrial quality control, Scaini et al. (125) have been able to show that BD patients presented a downregulation of mitophagy-related proteins, Parkin, p62/SQSTM1 and LC3A in PBMCs, followed by NLRP3-inflammasome activation. Here, PRKN is linked to Behcet disease.